Effects and Therapeutic Potential of Psilocybin in Alcohol Dependence

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

March 31, 2014

Conditions
Alcohol Dependence
Interventions
DRUG

Psilocybin

two doses of 0.3 mg/kg PO and 0.4 mg/kg PO, separated by 4 weeks in combination with 12 weeks of manualized outpatient psychosocial treatment including preparation, debriefing, and motivational enhancement therapy.

Trial Locations (1)

87131

University of New Mexico Health Sciences Center, Albuquerque

Sponsors
All Listed Sponsors
collaborator

Heffter Research Institute

OTHER

lead

University of New Mexico

OTHER